Chris Nave

BOARD REPRESENTATIVE

Founding Partner and Managing Director
Brandon Capital Partners
Level 9, 31 Queen Street
Melbourne VIC 3000

Chris is a founding partner of Brandon Capital Partners and Chief Executive Officer of the Medical Research Commercialisation Fund.

Chris previously was Director of Commercialisation at the Baker IDI Heart and Diabetes Institute, Melbourne, Australia. He was responsible for the commercialisation of technologies developed at the Baker and the Alfred Hospital, including the management of local and international spinout companies.

He is currently a Director of OccuRx Pty Ltd, Osprey Medical Inc., PolyActiva Pty Ltd, Global Kinetics Corporation, EBR Systems, QueOncology Pty Ltd, Azura Ophthalmics, Certa Therapeutics and Cardiora Pty Ltd. Chris was Chairperson of Fibrotech Therapeutics at the time of its successful sale to Shire and a Director of Spinifex Pharmaceuticals at the time of its sale to Novartis.

TO EMPOWER THE PRIVATE CAPITAL
INDUSTRY TO BUILD BETTER BUSINESSES

Head Office
Level 12, Aurora Place
88 Phillip Street
Sydney NSW 2000

Telephone
+61 2 8243 7000
—
Email Enquiry

Protect yourself from scams: the Australian Investment Council advises its members to be aware of text messages, phone calls, emails and other unsolicited contact that use the Australian Investment Council brand without our permission. We have been made aware of unrelated third parties seeking to sell the Australian Investment Council member list. The Australian Investment Council does not request payment for our member list.

Please report online scams and fraudulent activity to the Australian Taxation Office on 1300 795 995 or Scamwatch via their website.

Picture Logo
There are no records.